Evaluation of Dupilumab in Patients With Atopic Keratoconjunctivitis (AKC)

NCT04296864 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Keratoconjunctivitis

Interventions

DRUG: Dupilumab

Sponsor

Andover Eye Associates

Collaborators

[object Object]
[object Object]